|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Depreciation & amortization | |||||
| (Increase) decrease in value of equity securities | |||||
| Increase in value of equity method investments | |||||
| Amortization of securities, net | |||||
| Accretion of purchased loans | |||||
| Share-based compensation | |||||
| Gain on assets | |||||
| Gain on repurchase of subordinated debentures | |||||
| Provision for credit losses - loans | |||||
| Provision for credit losses on investment securities | |||||
| Recovery of credit losses - unfunded commitments | |||||
| Recovery of credit losses - investment securities | |||||
| Deferred income taxes | |||||
| Increase in cash value of life insurance | |||||
| Originations of mortgage loans held for sale | |||||
| Proceeds from sales of mortgage loans held for sale | |||||
| Changes in assets and liabilities: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Net decrease (increase) in federal funds sold | |||||
| Net increase in loans | |||||
| Purchases of investment securities – available-for-sale | |||||
| Purchases of investment securities - held-to-maturity | |||||
| Proceeds from maturities of investment securities – available-for-sale | |||||
| Proceeds from maturities of investment securities – held-to-maturity | |||||
| Proceeds from sale of investment securities – available-for-sale | |||||
| Purchases of equity securities | |||||
| Proceeds from sales of equity securities | |||||
| Purchases of other investments | |||||
| Proceeds from redemption of other investments | |||||
| OREO Improvements | |||||
| Proceeds from foreclosed assets held for sale | |||||
| Proceeds from sale of SBA loans | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sales of premises and equipment | |||||
| Return of (purchase of) investment on cash value of life insurance | |||||
| Purchase of marine loan portfolio | |||||
| Net cash proceeds received – market acquisitions | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing Activities | |||||
| Net increase (decrease) in deposits | |||||
| Net (decrease) increase in securities sold under agreements to repurchase | |||||
| Increase in FHLB and other borrowed funds | |||||
| Decrease in FHLB and other borrowed funds | |||||
| Retirement of subordinated debentures | |||||
| Redemption of trust preferred securities | |||||
| Proceeds from exercise of stock options | |||||
| Repurchase of common stock | |||||
| Dividends paid on common stock | |||||
| Net cash used in financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents – beginning of year | |||||
| Cash and cash equivalents – end of year | |||||
Loading...
